Hyderabad, Nov 22 : Dr. Reddy’s Laboratories Limited on Friday announced the launch of Doxercalciferol Injection, the therapeutic generic equivalent of Hectorol, in the US market.
The (doxercalciferol) Injection 4 mcg/2 mL (2 mcg/mL) Multiple-Dose Vials, was approved by the U.S. Food and Drug Administration (USFDA), Hyderabad-based pharmaceutical company said in a statement here.
The Hectorol® Injection 4 mcg/2 mL (2 mcg/mL) Single-Dose Vials and Multiple-Dose Vials brand and generics had U.S. sales of approximately $138 million MAT for the most recent 12 months ending in September 2019 according to IQVIA Health.
Hectorol is a trademark of Sanofi-Aventis US LLC. (UNI)